Original Literature | Model OverView |
---|---|
Publication
Title
Nuclear receptor signaling in macrophages.
Affiliation
Department of Cellular and Molecular Medicine, University of California, SanDiego, 9500 Gilman Drive, La Jolla, CA 92093-0651, USA.
Abstract
Macrophages play diverse roles in host defense and in maintenance ofhomeostasis. Based on their ability to promote inflammatory responses,inappropriate macrophage function also contributes to numerous pathologicalprocesses, including atherosclerosis, rheumatoid arthritis and inflammatorybowel disease. Members of the nuclear receptor superfamily of ligand-dependenttranscriptions factors have emerged as key regulators of inflammation and lipidhomeostasis in macrophages. These include the glucocorticoid receptor (GR),which inhibits inflammatory programs of gene expression in response to naturalcorticosteroids and synthetic anti-inflammatory ligands such as dexamethasone.Also, in response to endogenous eicosanoids and oxysterols, respectively,peroxisome proliferator-activated receptors (PPARs) and liver X receptors (LXRs)regulate transcriptional programs involved in inflammatory responses and lipidhomeostasis. Identification of their mechanisms of action should help guide thedevelopment of new therapeutic agents useful in the treatment of diseases inwhich macrophages play critical pathogenic roles.
PMID
14698033
|
Entity
GR (NR3C1)
--
MO000000050
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m47
10
infinite
0
InterPro | IPR001723 |
TRANSPATH | MO000000050 |
--
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m29
10
infinite
0
TRANSPATH | MO000000058 |
--
arachidonic acid
--
MO000000310
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m349736
10
infinite
0
TRANSPATH | MO000000310 |
--
VDR (NR1I1)
--
MO000021494
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m5839
10
infinite
0
InterPro | IPR001723 |
TRANSPATH | MO000021494 |
--
PPARgamma (NR1C3)
--
MO000022492
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6775
10
infinite
0
InterPro | IPR003077 |
TRANSPATH | MO000022492 |
--
PPARalpha (NR1C1)
--
MO000033504
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m12180
10
infinite
0
InterPro | IPR003074 |
TRANSPATH | MO000033504 |
--
PPARbeta (NR1C2)
--
MO000033505
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m12181
10
infinite
0
InterPro | IPR003074 |
TRANSPATH | MO000033505 |
--
SREBP-1c
--
MO000037246
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m15529
10
infinite
0
TRANSPATH | MO000037246 |
--
15d-PGJ2:PPARgamma (NR1C3)
--
MO000038949
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m17132
10
infinite
0
TRANSPATH | MO000038949 |
--
LXR
--
MO000056002
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m31326
10
infinite
0
TRANSPATH | MO000056002 |
--
cholesterol
--
MO000056221
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m360460
10
infinite
0
TRANSPATH | MO000056221 |
--
LDL receptor
--
MO000061802
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m36695
10
infinite
0
TRANSPATH | MO000061802 |
--
8(S)-HETE:PPARalpha (NR1C1)
--
MO000110538
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m82311
10
infinite
0
TRANSPATH | MO000110538 |
--
24(S)-hydroxycholesterol
--
MO000114348
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m356087
10
infinite
0
TRANSPATH | MO000114348 |
--
24(S),25-epoxycholesterol
--
MO000114356
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m359939
10
infinite
0
TRANSPATH | MO000114356 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
IFN-gamma:IFN-gammaR
--
e11
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m11
0
infinite
0
--
IFN-gammaR
--
e12
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m12
0
infinite
0
--
aromatase
--
e13
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m13
0
infinite
0
--
DHEA
--
e14
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m14
0
infinite
0
--
androstenedione
--
e15
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m15
0
infinite
0
--
3¦Â,17¦Â-androstenediol
--
e16
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m16
0
infinite
0
--
1,25(OH)2D3
--
e17
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m17
0
infinite
0
--
LTB4:PPAR-alpha
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m18
0
infinite
0
--
15-HETE:PPARgamma
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
13-HODE:PPARgamma
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
12/15-lipoxygenase
--
e21
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
csml-variable:Double
m22
0
infinite
0
--
IL4:IL4R
--
e23
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m23
0
infinite
0
--
22(R)-hydroxycholesterol
--
e24
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
CYP27
--
e25
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
24(S),25-epoxycholesterol:LXR
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
24(S)-hydroxycholesterol:LXR
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m27
0
infinite
0
--
22(R)-hydroxycholesterol:LXR
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m28
0
infinite
0
--
GR:AP1
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m30
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
GR:NF-kappaB
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m31
0
infinite
0
--
NF-kappaB{active}
--
e31
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m32
10
infinite
0
TRANSPATH | MO000000058 |
--
TGF-beta
--
e32
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m33
0
infinite
0
--
LDL:LDL receptor
--
e33
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m34
0
infinite
0
--
LDL receptor
--
e35
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m36
0
infinite
0
--
CD36
--
e36
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m37
0
infinite
0
--
oxLDL:CD36
--
e37
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m38
0
infinite
0
--
ABCA1
--
e38
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
phospholipids
--
e40
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m41
0
infinite
0
--
CEH
--
e42
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m43
0
infinite
0
--
SREBP-1C
--
e43
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
FASN
--
e44
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m45
0
infinite
0
--
stearoyl coenzyme A desaturase
--
e45
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
stearoyl coenzyme A desaturase
--
e46
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m48
0
infinite
0
--
LPS:TLRs
--
e5
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
IFN-gamma
--
e6
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c5 : 1
stoichiometry:c9 : 1
stoichiometry:c1 : 1
1.0*0.1
nodelay
--
0
PMID: 14698033, 12740443 interferon (IFN)-¦Ã and lipopolysaccharide (LPS) repress the expression of PPAR¦Ã.
p10
p10
cso30:i:ME_MetabolicReaction
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c36 : 1
stoichiometry:c32 : 1
m349736*m21*0.1
nodelay
--
0
PMID: 14698033, 10432118, 11726648 13-HODE and 15-HETE can be enzymatically generated by the IL-4 inducible 12/15-lipoxygenase, suggesting that IL-4 can coordinately regulate the expression and activity of PPAR¦Ã.
p11
p11
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m6775*m348490*0.1
nodelay
--
0
PMID: 14698033 ligands for PPAR-alpha are leukotriene (LT)B4 and 8(S)-hydroxyecosatetraenoic acid (HETE), whereas 15-deoxy-¦¤12,14-prostaglandin J2 (15d-PGJ2), 15-HETE and 13-hydroxyoctadecadienoic acid (HODE) act as ligands for PPAR¦Ã.
p12
p12
cso30:i:ME_MetabolicReaction
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c35 : 1
stoichiometry:c34 : 1
m349736*m21*0.1
nodelay
--
0
PMID: 14698033, 10432118, 11726648 13-HODE and 15-HETE can be enzymatically generated by the IL-4 inducible 12/15-lipoxygenase, suggesting that IL-4 can coordinately regulate the expression and activity of PPAR¦Ã.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c37 : 1
m23*0.1
nodelay
--
0
PMID: 14698033, 10432118, 11726648 13-HODE and 15-HETE can be enzymatically generated by the IL-4 inducible 12/15-lipoxygenase, suggesting that IL-4 can coordinately regulate the expression and activity of PPAR¦Ã.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c43 : 1
stoichiometry:c38 : 1
m22*m23*0.1
nodelay
--
0
PMID: 14698033, 10432118, 11726648 13-HODE and 15-HETE can be enzymatically generated by the IL-4 inducible 12/15-lipoxygenase, suggesting that IL-4 can coordinately regulate the expression and activity of PPAR¦Ã.
p15
p15
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m1952*m1947*0.1
nodelay
--
0
PMID: 14698033 IL4 binds to IL4R
p16
p16
cso30:i:ME_Oxidation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c53 : 1
stoichiometry:c46 : 1
m360460*m25*0.1
nodelay
--
0
PMID: 14698033, 11504730, 9334194 In macrophages, sterol 27-hydrolase (CYP27) is able to modify cholesterol into a naturally occurring ligand for LXRs. PMID: 14698033, 9874807, 14512442, 9013544, 8878485 LXRs are activated by specific oxidized forms of cholesterol (oxysterols)such as 24(S)-hydroxycholesterol and 22(R)-hydroxycholesterol, or by certain intermediates of the cholesterol biosynthetic pathway such as 24(S),25-epoxycholesterol.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c51 : 1
stoichiometry:c48 : 1
m360460*m25*0.1
nodelay
--
0
PMID: 14698033, 9874807, 14512442, 9013544, 8878485 LXRs are activated by specific oxidized forms of cholesterol (oxysterols)such as 24(S)-hydroxycholesterol and 22(R)-hydroxycholesterol, or by certain intermediates of the cholesterol biosynthetic pathway such as 24(S),25-epoxycholesterol. PMID: 14698033, 11504730, 9334194 In macrophages, sterol 27-hydrolase (CYP27) is able to modify cholesterol into a naturally occurring ligand for LXRs.
p18
p18
cso30:i:ME_MetabolicReaction
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c52 : 1
stoichiometry:c50 : 1
m360460*m25*0.1
nodelay
--
0
PMID: 14698033, 11504730, 9334194 In macrophages, sterol 27-hydrolase (CYP27) is able to modify cholesterol into a naturally occurring ligand for LXRs. PMID: 14698033, 9874807, 14512442, 9013544, 8878485 LXRs are activated by specific oxidized forms of cholesterol (oxysterols)such as 24(S)-hydroxycholesterol and 22(R)-hydroxycholesterol, or by certain intermediates of the cholesterol biosynthetic pathway such as 24(S),25-epoxycholesterol.
p19
p19
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c55 : 1
stoichiometry:c56 : 1
m359939*m31326*0.1
nodelay
--
0
PMID: 14698033, 9874807, 14512442, 9013544, 8878485 LXRs are activated by specific oxidized forms of cholesterol (oxysterols)such as 24(S)-hydroxycholesterol and 22(R)-hydroxycholesterol, or by certain intermediates of the cholesterol biosynthetic pathway such as 24(S),25-epoxycholesterol.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c2 : 1
stoichiometry:c3 : 1
stoichiometry:c4 : 1
m155666*m3962*0.1
nodelay
--
0
PMID: 14698033 LPS binds to TLRs.
p20
p20
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m31326*m356087*0.1
nodelay
--
0
PMID: 14698033, 9874807, 14512442, 9013544, 8878485 LXRs are activated by specific oxidized forms of cholesterol (oxysterols)such as 24(S)-hydroxycholesterol and 22(R)-hydroxycholesterol, or by certain intermediates of the cholesterol biosynthetic pathway such as 24(S),25-epoxycholesterol.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
stoichiometry:c62 : 1
m24*m31326*0.1
nodelay
--
0
PMID: 14698033, 9874807, 14512442, 9013544, 8878485 LXRs are activated by specific oxidized forms of cholesterol (oxysterols)such as 24(S)-hydroxycholesterol and 22(R)-hydroxycholesterol, or by certain intermediates of the cholesterol biosynthetic pathway such as 24(S),25-epoxycholesterol.
p22
p22
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c64 : 1
stoichiometry:c65 : 1
m47*m219*0.1
nodelay
--
0
PMID: 14698033, 7823959, 7659084 One established mechanism involves direct interaction between GR and negatively regulated transcription factors such as AP-1 and NF-¦ÊB.
p23
p23
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c67 : 1
stoichiometry:c68 : 1
m47*m29*0.1
nodelay
--
0
PMID: 14698033, 7823959, 7659084 One established mechanism involves direct interaction between GR and negatively regulated transcription factors such as AP-1 and NF-¦ÊB.
p24
p24
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c71 : 1
stoichiometry:c70 : 1
m29*0.1
nodelay
--
0
PMID: 14698033, 11726533 VDR also inhibits inflammatory gene expression by downregulating NF-¦ÊB activation or by inducing the expression of both transforming growth factor (TGF)-¦Â and IL-4.
p25
p25
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c72 : 1
m5839*0.1
nodelay
--
0
PMID: 14698033, 11726533 VDR also inhibits inflammatory gene expression by downregulating NF-¦ÊB activation or by inducing the expression of both transforming growth factor (TGF)-¦Â and IL-4.
p26
p26
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c74 : 1
m5839*0.1
nodelay
--
0
PMID: 14698033, 11726533 VDR also inhibits inflammatory gene expression by downregulating NF-¦ÊB activation or by inducing the expression of both transforming growth factor (TGF)-¦Â and IL-4.
p27
p27
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c76 : 1
1.0*0.1
nodelay
--
0
PMID: 14698033, 12970571 PPAR¦Ä represses inflammatory genes including the chemokine monocyte-chemoattractant protein-1 (MCP-1), IL-1¦Â and the metalloproteinase MMP-9 by an unconventional ligand-dependent transcriptional mechanism involving the binding of PPAR¦Ä to transcriptional repressors.
p28
p28
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c78 : 1
1.0*0.1
nodelay
--
0
PMID: 14698033, 12970571 PPAR¦Ä represses inflammatory genes including the chemokine monocyte-chemoattractant protein-1 (MCP-1), IL-1¦Â and the metalloproteinase MMP-9 by an unconventional ligand-dependent transcriptional mechanism involving the binding of PPAR¦Ä to transcriptional repressors.
p29
p29
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c80 : 1
1.0*0.1
nodelay
--
0
PMID: 14698033, 12970571 PPAR¦Ä represses inflammatory genes including the chemokine monocyte-chemoattractant protein-1 (MCP-1), IL-1¦Â and the metalloproteinase MMP-9 by an unconventional ligand-dependent transcriptional mechanism involving the binding of PPAR¦Ä to transcriptional repressors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c6 : 1
stoichiometry:c8 : 1
stoichiometry:c7 : 1
m12*m6*0.1
nodelay
--
0
PMID: 14698033 IFN-gamma binds to IFN-gammaR.
p30
p30
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c83 : 1
stoichiometry:c84 : 1
m36695*m290118*0.1
nodelay
--
0
PMID: 14698033, 3513311 Like most cells, macrophages take up circulating lipoproteins via the low-density lipoprotein (LDL) receptor.
p31
p31
cso30:i:ME_Cleavage
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c87 : 1
stoichiometry:c86 : 1
m229*0.1
nodelay
--
0
PMID: 14698033, 9150132 Excess cholesterol inhibits proteolytic activation of sterol regulatory element binding proteins (SREBPs), which are transcription factors that promote cholesterol and triglyceride biosynthesis and LDL receptor expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c88 : 1
m35*0.1
nodelay
--
0
PMID: 14698033, 9150132 Excess cholesterol inhibits proteolytic activation of sterol regulatory element binding proteins (SREBPs), which are transcription factors that promote cholesterol and triglyceride biosynthesis and LDL receptor expression.
p33
p33
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c91 : 1
stoichiometry:c92 : 1
m341431*m37*0.1
nodelay
--
0
PMID: 14698033, 9823020 Resident macrophages also secrete molecules that modify extracellular LDL, e.g. by oxidation (oxLDL), converting it into a form that is efficiently recognized by macrophage scavenger receptors, such as CD36.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c94 : 1
stoichiometry:c93 : 1
m26*0.1
nodelay
--
0
PMID: 14698033, 10858438, 10968783, 11035776, 10924356 Studies have established the connection between nuclear receptor action and reverse cholesterol transport by demonstrating that LXRs directly regulate ABCA1 expression and cholesterol efflux in human and murine cells, including macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c103 : 1
stoichiometry:c96 : 1
m95583*m26*0.1
nodelay
--
0
PMID: 14698033, 10858438, 10968783, 11035776, 10924356 Studies have established the connection between nuclear receptor action and reverse cholesterol transport by demonstrating that LXRs directly regulate ABCA1 expression and cholesterol efflux in human and murine cells, including macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c97 : 1
stoichiometry:c99 : 1
stoichiometry:c98 : 1
m40*m39*0.1
nodelay
--
0
PMID: 14698033, 10882340 ABCA1 transports intracellular phospholipids and cholesterol to exogenous nascent HDL particles, which contain lipid-poor apolipoprotein (apo) acceptors, such as apoAI.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c100 : 1
stoichiometry:c102 : 1
stoichiometry:c101 : 1
m360460*m39*0.1
nodelay
--
0
PMID: 14698033, 10882340 ABCA1 transports intracellular phospholipids and cholesterol to exogenous nascent HDL particles, which contain lipid-poor apolipoprotein (apo) acceptors, such as apoAI.
p38
p38
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c104 : 1
m82311*0.1
nodelay
--
0
PMID: 14698033, 11172721, 11135616 PPARalpha and PPAR¦Ã upregulate the expression of ABCA1 and promote cholesterol efflux in human macrophages through a transcriptional cascade mediated by LXR-alpha.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c106 : 1
m20*0.1
nodelay
--
0
PMID: 14698033, 11172721, 11135616 PPARalpha and PPAR¦Ã upregulate the expression of ABCA1 and promote cholesterol efflux in human macrophages through a transcriptional cascade mediated by LXR-alpha.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c13 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m14*m13*0.1
nodelay
--
0
PMID: 14698033, 10657851 macrophages express and regulate the enzyme aromatase, which converts serum dehydroepiandrosterone (DHEA) into the immunomodulatory estrogens 3¦Â,17¦Â-androstenediol and androstenedione.
p40
p40
cso30:i:ME_GeneExpression
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c110 : 1
stoichiometry:c108 : 1
1.0*0.1
nodelay
--
0
PMID: 14698033, 11409902, 12574149 PPAR alpha and PPAR¦Ã have been also shown to down-regulate the expression of macrophage cholesteryl ester hydrolase (CEH), an enzyme required for hydrolysis and release of cholesterol from foam cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c111 : 1
m20*0.1
nodelay
--
0
PMID: 14698033, 12740443, 11909955, 10799558 LXRs and PPAR¦Ã are able to directly induce the expression of another member of the ATP binding cassette family, ABCG1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c113 : 1
m26*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c115 : 1
m26*0.1
nodelay
--
0
PMID: 14698033, 11090130, 11287605 In many cellular types, including macrophages, the expression of the transcription factor SREBP-1c is induced by LXR activation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c119 : 1
stoichiometry:c117 : 1
m44*m26*0.1
nodelay
--
0
PMID: 14698033, 11090130, 11287605 In many cellular types, including macrophages, the expression of the transcription factor SREBP-1c is induced by LXR activation.
p45
p45
cso30:i:ME_GeneExpression
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c120 : 1
m15529*0.1
nodelay
--
0
PMID: 14698033 SREBP1c positively regulates the expression of a number of enzymes involved in fatty acid synthesis and triglyceride formation, including fatty acid synthase and stearoyl coenzyme A desaturase.
p46
p46
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c122 : 1
stoichiometry:c124 : 1
stoichiometry:c123 : 1
m93432*m15529*0.1
nodelay
--
0
PMID: 14698033 SREBP1c positively regulates the expression of a number of enzymes involved in fatty acid synthesis and triglyceride formation, including fatty acid synthase and stearoyl coenzyme A desaturase.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c126 : 1
m15529*0.1
nodelay
--
0
PMID: 14698033 SREBP1c positively regulates the expression of a number of enzymes involved in fatty acid synthesis and triglyceride formation, including fatty acid synthase and stearoyl coenzyme A desaturase.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c127 : 1
stoichiometry:c129 : 1
stoichiometry:c128 : 1
m46*m15529*0.1
nodelay
--
0
PMID: 14698033 SREBP1c positively regulates the expression of a number of enzymes involved in fatty acid synthesis and triglyceride formation, including fatty acid synthase and stearoyl coenzyme A desaturase.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c14 : 1
m5*0.1
nodelay
--
0
PMID: 14698033, 8078106, 12855575 Following LPS stimulation microglia and dendritic cells are able to produce 1,25(OH)2D3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m341991*m12180*0.1
nodelay
--
0
PMID: 14698033 ligands for PPAR-alpha are leukotriene (LT)B4 and 8(S)-hydroxyecosatetraenoic acid (HETE), whereas 15-deoxy-¦¤12,14-prostaglandin J2 (15d-PGJ2), 15-HETE and 13-hydroxyoctadecadienoic acid (HODE) act as ligands for PPAR¦Ã.
p7
p7
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m12180*m341864*0.1
nodelay
--
0
PMID: 14698033 ligands for PPAR-alpha are leukotriene (LT)B4 and 8(S)-hydroxyecosatetraenoic acid (HETE), whereas 15-deoxy-¦¤12,14-prostaglandin J2 (15d-PGJ2), 15-HETE and 13-hydroxyoctadecadienoic acid (HODE) act as ligands for PPAR¦Ã.
p8
p8
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m6775*m353530*0.1
nodelay
--
0
PMID: 14698033 ligands for PPAR-alpha are leukotriene (LT)B4 and 8(S)-hydroxyecosatetraenoic acid (HETE), whereas 15-deoxy-¦¤12,14-prostaglandin J2 (15d-PGJ2), 15-HETE and 13-hydroxyoctadecadienoic acid (HODE) act as ligands for PPAR¦Ã.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m6775*m348485*0.1
nodelay
--
0
PMID: 14698033 ligands for PPAR-alpha are leukotriene (LT)B4 and 8(S)-hydroxyecosatetraenoic acid (HETE), whereas 15-deoxy-¦¤12,14-prostaglandin J2 (15d-PGJ2), 15-HETE and 13-hydroxyoctadecadienoic acid (HODE) act as ligands for PPAR¦Ã.
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--